Waypoint Capital Advisors’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-47,583
Closed -$2.5M 128
2023
Q2
$2.5M Hold
47,583
0.78% 35
2023
Q1
$3.04M Hold
47,583
0.99% 31
2022
Q4
$2.31M Buy
+47,583
New +$2.98M 0.8% 36
2022
Q2
Sell
-22,583
Closed -$1.49M 134
2022
Q1
$1.49M Buy
+22,583
New +$1.68M 0.87% 31

Other funds holding STAA

Waypoint Capital Advisors's STAA Position: Q3 2023 in Review

Waypoint Capital Advisors sold out of STAAR Surgical (STAA) in Q3 2023, closing a stake of 47,583 shares — an estimated $2.5M sold.

Waypoint Capital Advisors first reported a position in STAA in Q1 2022 and held it in 4 quarters. The position peaked at $3.04M in Q1 2023. 217 funds tracked by Wall St. Rank hold STAA as of Q3 2023.

  • Waypoint Capital Advisors reported no remaining STAAR Surgical position as of Q3 2023 after selling out during the quarter.
  • Waypoint Capital Advisors sold 47,583 STAAR Surgical shares in Q3 2023, an estimated $2.5M.
  • Waypoint Capital Advisors first reported a position in STAAR Surgical in Q1 2022 and held it in 4 quarters.
  • Waypoint Capital Advisors's STAAR Surgical position peaked at $3.04M in Q1 2023.
  • 217 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2023.

Based on Waypoint Capital Advisors's 13F filing for Q3 2023, filed 25 Oct 2023.